logo

Indonesia Clinical Laboratory Market Outlook to 2022

By Type (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), By Type of Test (Routine, Non Laboratory and Esoteric)

Region:Asia

Product Code:KR588

Download Sample Report
Published On

February 2018

Total pages

93

About the Report

 
The report titled "Indonesia Clinical Laboratory Market Outlook to 2022 - By Type (Public Clinical Lab, Private Hospital Labs, and Private Independent Labs), By Type of Test (Routine, Non-Laboratory and Esoteric)” provides information on market size for Indonesia Healthcare and clinical laboratory. The report covers aspects such as clinical laboratory market segment (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region), competitive landscape of major players in Indonesia clinical laboratory market covering company profile of major labs including Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika and Parahita. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions. 
Indonesia Clinical Laboratory Market
 
Indonesia Clinical Laboratory Market Overview: Indonesia clinical laboratory market increased from USD ~ million in 2012 to USD ~ million in 2017 at a CAGR of ~%. The industry has witnessed expansion of private laboratory chains and use of advanced technology in order to provide high quality laboratory services. The largest private laboratory chain, Prodia established 9 new labs during 2012 to 2017. Prodia’s number of clinical laboratory increased from ~ in 2012 to ~ in 2017. During this period, the self-caring attitude among the people has led to more number of diagnostic tests, hence generating revenue for the market. Due to growing awareness amongst people about healthy living, private and public laboratories have witnessed an increase in walk-in patients asking for routine checkups which is funded out of the patient’s pocket.
 

Indonesia Clinical Laboratory Segmentation

By Type of Laboratory: The public clinical labs have accounted for ~% of the revenue share in Indonesia clinical laboratory market in 2017. Private hospital labs have accounted for ~% in 2017 and private independent labs with ~% of the overall market.

By Type of Private Independent Laboratory
: The laboratory chains such as Prodia, Kimia Farma Diagnostik, Pramita, Cito, BioMedika and Parahita have together accounted for ~% of revenue the overall private independent laboratory market in 2016. Single independent labs have contributed to their lower revenue share of ~% due to their restricted geographic presence.

By Type of Customer in Private Independent Laboratory
: Doctor Referrals have accounted for the largest share of ~% of the tests in Indonesia Private independent laboratory market in 2016. With growing awareness about chronic diseases and their treatment procedure increasing number of Indonesians have taken charge of their own health. This has led to an increase in number of walk-ins at medical laboratories which has registered ~% of the tests. This is followed by corporate clients with ~% of the tests and external referrals with ~% of the total tests in 2016.

By Payer in Private Independent Laboratory
: Corporates have accounted for the largest share of ~% of the number of tests in Indonesia Private Independent Laboratory Market in 2016. This is followed by private health insurance companies with ~% of the number of tests, out of pocket with ~% and BPJS with ~% of the number of tests in 2016.

By Type of Tests in Private Independent Laboratory
: Routine tests have accounted for ~% of the revenue in Indonesia Private independent laboratory market in 2016. This is followed by esoteric tests with ~% and non laboratory tests with ~% of the overall private independent laboratory market.
 
By Region: Java, Sumatra, Bali, Jakarta and Palembang have together accounted for ~% of the revenue in the overall private laboratory market in 2016. This is driven by high rate of urbanization and more affluent population, which has created greater demand for private clinical laboratory testing services. Underdeveloped cities such as Sulawesi, Maluku and Kalimantan have together accounted for ~% of the revenue in 2016.

Indonesia Clinical Laboratory Competitive Landscape:
Indonesia clinical laboratories market can be segmented into public clinical labs and private clinical labs. The public clinical labs capabilities are restricted to routine tests such as glucose, lipid profile and urine tests. Private and public hospital labs find it more cost-effective to outsource low demand, specialized tests, such as microbiology, anatomical pathology and esoteric tests due to the high cost of the laboratory equipment. The private independent clinical laboratory market is organized and is composed of both chain laboratories and stand-alone laboratories. The chain laboratories are the leading market players in Indonesia. The 6 major players in the industry are Prodia, Kimia Farma, Pramita, Cito, BioMedika and Parahita. They have together accounted for ~% of the revenue share in private independent laboratory market in 2017. The major players compete on distribution network, product portfolio, advertising, technology, Prices and services.

Indonesia Clinical Laboratory Future Outlook:
The clinical laboratory market is expected to reach USD ~ billion by 2022 growing at a CAGR of ~%. The major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. It is also expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories. Further, the industry will witness a rising trend towards precision medicine also known as personalized medicine. Further, the market for rapid tests will grow at a CAGR of 13% between 2016 and 2021 in Indonesia. The growth will be driven by factors such as increasing rate of infectious diseases such as dengue, malaria, hepatitis, and HIV, the government’s healthcare initiatives, and product advancements and innovations by rapid test manufacturers.
 

Key Topics Covered in the Report:

  • Indonesia Healthcare Market Size, 2012-2017
  • Indonesia Clinical Laboratory Market Size, 2012-2017
  • Indonesia Clinical Laboratory Market Segmentation (By Type Of Clinical Laboratory, By Type of Private Independent Laboratory, By Type Of Customer, By Payer, By Type Of Test And By Region)
  • Trends and Developments in Indonesia Clinical Laboratory Market
  • Issues and Challenges in Indonesia Clinical Laboratory Market
  • Government Initiatives, Rules and Regulations in Indonesia Clinical Laboratory Market
  • Indonesia Clinical Laboratory Market Competitive Landscape
  • Indonesia Clinical Laboratory Future Outlook and Projections, 2018-2022
  • Macro-economic Factors Impacting Indonesia Healthcare Market

Products

The clinical laboratory market is expected to increase 1.5 times by 2022 supported by higher growth in esoteric tests segment.

Companies

  • Prodia,
  • Kimia Farma Diagnostika,
  • Pramita,
  • Cito,
  • BioMedika and Parahita

Table of Contents

1. Executive Summary

Indonesia Healthcare Market Overview
Indonesia Clinical Laboratory Market Overview
Indonesia Clinical Laboratory Segmentation
Indonesia Clinical Laboratory Competitive Landscape
Indonesia Clinical Laboratory Future outlook

2. Research Methodology

2.1. Market Definitions
2.1. Abbreviations
2.2. Market Size and Modeling
Consolidated Research Approach
Market Sizing – Clinical Laboratories Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion

3. Indonesia Healthcare Market Size, 2012-2017

4. Indonesia Clinical Laboratory Market Introduction

4.1. Indonesia Clinical Laboratory Market Size, 2012-2017

5. Indonesia Clinical Laboratory Market Segmentation

5.1. By Type of Laboratory (Public Clinical Lab, Private Hospital Labs and Private Independent Labs), 2012-2017
5.2. Indonesia Private Independent Laboratory Market Segmentation
By Type of Private Independent Laboratory (Laboratory Chains and Single Independent Laboratory), 2015 & 2016
By Type of Customer (Doctor Referrals, Walk-Ins, Corporate Clients and External Referrals), 2016
By Payer (Private Health Insurance, Corporates, Out of Pocket and BPJS), 2016
By Type of Test (Routine, Non Laboratory and Esoteric), 2016
By Region, 2016

6. Value Chain of Clinical Labs Market

7. Trends, Developments, Issues and Challenges in Indonesia Clinical Laboratory Market

Universal Health Coverage (UHC) Increases The Demand For Clinical Laboratory Testing
Rising Prevalence of Non-Communicable Diseases (NCDs) and Communicable Diseases (CDs)
Increasing Demand For Health Check-Ups
Introduction of New Specialized Tests
Shortage of Skilled Human Resource Limits Growth
Limitations in Reimbursement per Case Load by BPJS May Limit the Extent of Tests Performed
Failure of Hub-and-Spoke Model

8. Government Regulations for Indonesia Clinical Laboratories Market

Classification And Licenses Of Clinical Laboratories
License Application Process
Regulation for Setting up Clinical Laboratory in Indonesia
Regulations on Transport of Tests and Quality Control Management
Regulation for Transporting Samples Abroad
Specimen Collection Point / Hospital Laboratory
Relevant Regulations On The Medical Personnel Law
Foreign Investment Restrictions

9. Competition Scenario for Indonesia Clinical Laboratories Market

9.1. Market Share of Major Organized Clinical Laboratories in Indonesia, 2016

10. Competitive Landscape of Major Organized Diagnostics Labs in Indonesia

10.1. Prodia
10.2. Kimia Farma Diagnostika
10.3. Pramita
10.4. Cito
10.5. BioMedika
10.6. Parahita

11. Indonesia Clinical Laboratory Market Future Outlook and Projections, 2018-2022

11.1. By Type of Private Independent Laboratory (Laboratory Chains and Single Independent Laboratory), 2022
11.2. By Type of Test (Routine, Non Laboratory and Esoteric), 2022

12. Analyst Recommendation

13. Macro Economic Factors Affecting Indonesia Healthcare Market

13.1. Population, 2012-2022
13.2. Number of Health Centers, 2012-2022
13.3. Budget Allocation on Healthcare, 2012-2022

13.4. Obese Population, 2012-2022

Disclaimer

Contact Us

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022